Creating dermatology guidelines for COVID-19: The pitfalls of applying evidence-based medicine to an emerging infectious disease
- PMID: 32278795
- PMCID: PMC7194997
- DOI: 10.1016/j.jaad.2020.04.002
Creating dermatology guidelines for COVID-19: The pitfalls of applying evidence-based medicine to an emerging infectious disease
Comment on
-
Modernizing clinical practice guidelines for the American Academy of Dermatology.J Am Acad Dermatol. 2020 Jun;82(6):1487-1489. doi: 10.1016/j.jaad.2019.12.075. Epub 2020 Jan 21. J Am Acad Dermatol. 2020. PMID: 31972259 Free PMC article.
References
-
- Emanuel E.J., Persad G., Upshur R. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med. 2020 - PubMed
-
- Heart Failure Society of America Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician: statement from the American Heart Association, the Heart Failure Society of America and the American College of Cardiology. 2020. https://www.hfsa.org/patients-taking-ace-i-and-arbs-who-contract-covid-1... Available at:
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
